Diaz, Vecinta O.

HRN: 14-68-90  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2026
CEFTRIAXONE 1G (VIAL)
06/16/2026
06/22/2026
IV
2g
Od
DM Foot
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: